Clinical Trial Update: Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart [Phase 1]

View source ↗

Summary

Phase 1 study comparing pharmacodynamic and pharmacokinetic effects of insulin glulisine versus insulin aspart after a standard meal in obese adults with Type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)
• NovoLog (insulin aspart)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED